However, in the recent decade, greater emphasis on molecular biomarkers such as microsatellite instability (MSI) [36], kirsten rat sarcoma virus (KRAS) [36], circulating tumor DNA (ctDNA) [37], and miRNAs [38], improves the accuracy of prognostication. Here, KRAS is linked to neoplasm.